ImmuCell Corporation

Rentabilité sur six mois: +27.01%
Rendement en dividendes: 0%
Secteur: Healthcare

6.49 $

0 $ 0%
3.53 $
6.87 $

paper.min_max_per_year

Calendrier des promotions ImmuCell Corporation

À propos de l'entreprise ImmuCell Corporation

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

Paramètres de base

IPO date
1987-04-30
ISIN
US4525253062
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт

Grade

Sous-estimation
Nom Signification Grade
P/S 1.49 9
P/BV 1.43 9
P/E 0 0
Efficacité
Nom Signification Grade
ROA -4.85 0
ROE -8.21 0
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA 14.46 0
Debt/Ratio 0.3348 10
Debt/Equity 0.6389 9
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 73.16 8
Rentabilité Ebitda, % -174.6 0
Rentabilité EPS, % 86.36 9

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 6.49 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 6.29 $ 0 $ 0 $ 3.18 % 0 % 0 %
common.calendar.number_days.30d 6.52 $ 6.26 $ 6.75 $ -0.46 % 0 % 0 %
common.calendar.number_days.90d 5.41 $ 4.81 $ 6.87 $ 19.96 % 0 % 0 %
common.calendar.number_days.180d 5.11 $ 4.78 $ 6.87 $ 27.01 % 0 % 0 %
common.calendar.number_days.1y 3.8 $ 3.53 $ 6.87 $ 70.79 % 0 % 0 %
common.calendar.number_days.3y 7.4 $ 3.53 $ 9.1 $ -12.3 % 0 % 0 %
common.calendar.number_days.5y 5.61 $ 3.53 $ 11.88 $ 15.69 % 0 % 0 %
common.calendar.number_days.10y 3.53 $ 3.53 $ 11.88 $ 183.85 % 0 % 0 %
common.calendar.number_days.ytd 5.3 $ 4.78 $ 6.87 $ 22.45 % 0 % 0 %

Principaux propriétaires

Entreprises similaires



Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Michael F. Brigham President, CEO, Principal Financial Officer, Treasurer, Secretary & Director 395.24k 1961 (64 année)
Ms. Bobbi Jo Brockmann VP of Sales & Marketing and Director 323.52k 1977 (48 années)
Mr. A. Gustavo Scaffa Senior Director of Quality N/A
John W. Zinckgraf Director of Product Development N/A
Ms. Elizabeth L. Williams Vice President of Manufacturing Operations 312.07k 1956 (69 années)
Ms. Elizabeth S. Toothaker Director of Finance & Administration and Controller N/A

Informations sur l'entreprise

Adresse: United States, Portland. ME, 56 Evergreen Drive - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://immucell.com